Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 1/20 | 0.66 |
| ▸ | CDK4 | P11802 | 4/20 | 0.62 |
| ▸ | CCND1 | P24385 | 4/20 | 0.62 |
| ▸ | CCNE1 | P24864 | 3/20 | 0.62 |
| ▸ | CDK2 | P24941 | 3/20 | 0.62 |
| ▸ | SYK | P43405 | 3/20 | 0.57 |
| ▸ | ALK | Q9UM73 | 4/20 | 0.55 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.52 |
| ▸ | JAK2 | O60674 | 3/20 | 0.52 |
| ▸ | BRD4 | O60885 | 3/20 | 0.52 |
| ▸ | FGFR2 | P21802 | 1/20 | 0.52 |
| ▸ | TTK | P33981 | 2/20 | 0.50 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.50 |
| ▸ | CDK1 | P06493 | 1/20 | 0.50 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18376646 | 1.00 | EGFR (0.66) | EGFRCDK4CCND1CCNE1CDK2 | |
| SCHEMBL18376777 | 0.91 | EGFR (0.60) | EGFRCDK4CCND1CCNE1CDK2 | |
| SCHEMBL29368867 | 0.91 | EGFR (0.60) | EGFRCDK4CCND1CCNE1CDK2 | |
| SCHEMBL18376602 | 0.89 | EGFR (0.71) | EGFRCDK4CCND1CCNE1CDK2 | |
| SCHEMBL18376592 | 0.89 | EGFR (0.68) | EGFRCDK4CCND1CCNE1CDK2 | |
| SCHEMBL29372582 | 0.89 | EGFR (0.68) | EGFRCDK4CCND1CCNE1CDK2 | |
| SCHEMBL18377046 | 0.88 | BRD4 (0.63) | EGFRCDK4CCND1CDK2MAPK10 | |
| SCHEMBL29368354 | 0.88 | CDK4 (0.57) | EGFRCDK4CCND1CCNE1CDK2 | |
| SCHEMBL18376599 | 0.88 | CDK4 (0.57) | EGFRCDK4CCND1CCNE1CDK2 | |
| SCHEMBL18376650 | 0.88 | EGFR (0.52) | EGFRCDK4CCND1CCNE1CDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113999180-A | Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application | 上海医药集团股份有限公司 | 2022-02-01 | — | — | CN | claimed |
| CN-113999180-B | Quinazoline compound, intermediate, preparation method, pharmaceutical composition and application | 上海医药集团股份有限公司 | 2024-03-26 | — | — | CN | disclosed |
| CN-113999180-A | Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application | 上海医药集团股份有限公司 | 2022-02-01 | — | — | CN | disclosed |